Skip to content

Empowered by Independence

People with spinal cord injury (SCI) will enjoy
life in the ways that matter to them.

ARC Therapy™ is targeted, programmed electrical stimulation of the spinal cord to restore movement, function, and independence in people with SCI.

Our Therapy

Pioneering Science

Our work builds on decades of
research and translational
science by giants in this
important and emerging field

“Functional recovery once deemed impossible may now be in reach.”

Marco Baptista, Ph.D., Chief Scientific Officer

Christopher & Dana Reeve Foundation

Discover Our Therapy

Investigational ARC Therapy is targeted, programmed stimulation of the spinal cord to restore movement and autonomic function after spinal cord injury (SCI).

Our current plans include commercializing ARC Therapy to restore movement of the upper and lower limbs and to stabilize blood pressure after SCI. Based on a clinical feasibility study, ARC Therapy also has the potential to help those living with Parkinson’s disease address movement challenges, such as freezing of gait. We also plan to investigate the potential for ARC Therapy to help people who have suffered a stroke.

ARC Therapy is designed to be delivered by our external, non-invasive ARCEX® or implantable, minimally-invasive ARCIM® technology platform. We are also developing AI-driven brain-computer interface technology, called ARCBCI™.

Read Our Publications

    Learn more

    ARC Therapy Evidence

    We have a growing body of evidence for multiple indications across both our external and implantable technology platforms

    This is a example

    ARCEX Therapy

    Nearly 120 participants across 8 clinical feasibility studies, the Up-LIFT pivotal trial, and the LIFT Home study

    ARCIM Therapy

    Nearly 30 patients across 4 clinical feasibility studies for blood pressure stability, 3 clinical feasibility studies for mobility, and a clinical feasibility study for Parkinson’s disease

    ARCIM Therapy + BCI

    2 study participants using ARCIM Therapy augmented by an implanted brain-computer interface to restore thought-driven movement

    Learn more

    Be an ARC Therapy Investigator

    If you are interested in conducting
    an Investigator Initiated Study or
    joining an already planned study, please email research@onwd.com

    Sign up for clinician updates here
    All ONWARD® Medical devices and therapies referenced here, including but not limited to ARCIM®, ARCEX®, ARCBCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.